Research & Development

How to Navigate FDA Rules for CAR-NK Cell Therapies?
Research & Development How to Navigate FDA Rules for CAR-NK Cell Therapies?

In the rapidly advancing field of cancer treatment, chimeric antigen receptor natural killer (CAR-NK) cell therapies stand out as a groundbreaking approach, offering scalable, off-the-shelf solutions that could transform patient care. These therapies, often developed from induced pluripotent stem

Optimal Blastocyst Count for PGT-A in RPL Patients Unveiled
Research & Development Optimal Blastocyst Count for PGT-A in RPL Patients Unveiled

Recurrent pregnancy loss, often referred to as RPL and characterized by two or more consecutive miscarriages, casts a heavy shadow over the dreams of countless couples hoping to build a family. For those navigating the complex world of in vitro fertilization (IVF), a beacon of hope emerges through

Uncovering Chemoresistance in BRCA2-Deficient Tumors
Research & Development Uncovering Chemoresistance in BRCA2-Deficient Tumors

What happens when a tumor outsmarts the very treatments designed to destroy it, turning a lifeline into a losing battle for countless patients? In the relentless fight against breast and ovarian cancers tied to BRCA2 deficiencies, a staggering reality emerges: chemotherapy often fails as tumors

23-Year Study Confirms PSA Screening Cuts Prostate Cancer Deaths
Research & Development 23-Year Study Confirms PSA Screening Cuts Prostate Cancer Deaths

Every year, countless men face a silent threat that often goes undetected until it’s too late—prostate cancer, which stands as one of the leading causes of cancer-related deaths among men globally. This disease claims lives with a stealth that makes early detection both a challenge and a necessity.

How Is eConsent Transforming Clinical Trials Digitally?
Research & Development How Is eConsent Transforming Clinical Trials Digitally?

The landscape of clinical trials is undergoing a seismic shift as digital innovations reshape every aspect of research, with electronic consent (eConsent) emerging as a pivotal force in this transformation, especially as trials adopt decentralized and hybrid frameworks to accommodate diverse and

Jupiter Lab Targets HIV Cure with Innovative Drug Research
Research & Development Jupiter Lab Targets HIV Cure with Innovative Drug Research

In a world where HIV continues to impact millions globally, a groundbreaking effort at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter, Florida, is sparking hope for a transformative solution. This research hub has embarked on an ambitious journey to

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later